Thermo Fisher Scientific (NY:TMO)

Eli Lilly’s $47.8 Billion Masterstroke: The Contessa Acquisition and the New Era of Pharmaceutical Dominance

April 01, 2026

INDIANAPOLIS — In a move that has sent shockwaves through the global financial markets, Eli Lilly and Company (NYSE: LLY) announced early this morning, April 1, 2026, a definitive agreement to acquire...

Topics Artificial Intelligence Economy

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026

April 01, 2026

The Often-Missed Corner of Healthcare That Wall Street Is Loving ↗

March 29, 2026

Via MarketBeat

Thermo Fisher Scientific (NYSE:TMO) Beats Q4 Estimates and Details Growth Strategy ↗

January 29, 2026

Via Chartmill

Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.

March 24, 2026

As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...

Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks

March 09, 2026

MercadoLibre provides e-commerce and fintech solutions across Latin America, linking merchants and consumers through its digital platform.

Topics Artificial Intelligence Economy Intellectual Property

Kemnay Loads Up MercadoLibre With 1,385 Shares in Q4 Buy ↗

March 04, 2026

The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026

Topics Regulatory Compliance

February 27, 2026

WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the...

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Topics Earnings Economy World Trade

1 Large-Cap Stock to Target This Week and 2 Facing Challenges

February 26, 2026

Thermo Fisher Scientific Increases Quarterly Dividend

February 25, 2026

Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference

February 24, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

3 S&P 500 Stocks We’re Skeptical Of

February 23, 2026

As of February 17, 2026, Danaher Corporation (NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington,...

Topics Intellectual Property Stocks

Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot

February 17, 2026

Via Finterra

Topics Artificial Intelligence Earnings Supply Chain

Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset

February 11, 2026

Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has long been a cornerstone of the global healthcare infrastructure. However, as of February 11, 2026, the company is making headlines not...

Via Finterra

Topics Artificial Intelligence Economy Intellectual Property

The Measurement Giant Reimagined: A Deep Dive into Waters Corporation (WAT) in 2026

February 10, 2026

As of February 10, 2026, Waters Corporation (NYSE: WAT) stands at the most significant crossroads in its nearly 70-year history. Long regarded as the gold standard in liquid chromatography and mass...

Via Finterra

Topics Economy

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

February 09, 2026

Wall Street expects Nvidia's earnings to surge this year -- and the valuation looks compelling.

This Top Artificial Intelligence (AI) Stock Could Have More Upside in 2026 ↗

February 09, 2026

Thermo Fisher’s 22.9% return over the past six months has outpaced the S&P 500 by 14.4%, and its stock price has climbed to $551.55 per share. This was partly thanks to its solid quarterly results, and...

Topics Artificial Intelligence Supply Chain

3 Reasons to Sell TMO and 1 Stock to Buy Instead

February 05, 2026

Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging...

Topics Stocks

Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation

February 05, 2026

Via Finterra

Topics Artificial Intelligence Earnings Economy

5 Insightful Analyst Questions From Thermo Fisher’s Q4 Earnings Call

February 05, 2026

Thermo Fisher’s fourth quarter results exceeded Wall Street’s top-line and non-GAAP profit expectations, yet the market responded negatively, reflecting investor concerns beyond headline beats....

Topics Earnings World Trade

C WorldWide Group Loads Up 45,000 MercadoLibre Shares Worth $94 Million ↗

February 04, 2026

TMO Q4 Deep Dive: Product Innovation and Strategic Acquisitions Drive Mixed Market Reaction

January 30, 2026

Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 7.2% year on year to $12.22 billion. Its non-GAAP profit of $6.57 per...

Thermo Fisher (TMO) Q4 2025 Earnings Transcript

Topics World Trade

Thermo Fisher (TMO) Q4 2025 Earnings Transcript ↗

January 29, 2026

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.2% year on year to $12.22 billion. Its non-GAAP profit of $6.57 per...

Topics World Trade

Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q4 CY2025

January 29, 2026

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results

January 29, 2026

Life sciences company Thermo Fisher (NYSE:TMO) will be reporting results this Thursday before market hours. Here’s what investors should know.

Thermo Fisher (TMO) Q4 Earnings: What To Expect

January 27, 2026

Abbott Laboratories (NYSE: ABT) saw its stock price tumble by nearly 10% in early trading on January 22, 2026, following the release of its fourth-quarter 2025 financial results. Despite meeting...

Topics Artificial Intelligence

Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness

January 22, 2026

The morning of January 20, 2026, 3M (NYSE: MMM) released its fourth-quarter and full-year 2025 financial results, signaling a definitive turn in the company’s multi-year effort to shed its image as a...

Topics Economy

Industrial Resilience: 3M Exceeds 2025 Targets as CEO Bill Brown Plots Growth for 2026

January 20, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Topics Artificial Intelligence Economy Lawsuit

1 Mooning Stock to Own for Decades and 2 We Question

January 19, 2026